A Zanchetti, LM Ruilope - Journal of hypertension, 2002 - pdfs.journals.lww.com Findings Evidence that association of type-2 diabetes with hypertension markedly
increases cardiovascular and renal risk is incontrovertible: even blood pressure
values in the high-normal range represent a more relevant risk than in non- ... Cited by 128 - Related articles - BL Direct - All 5 versions
R Harris, K Donahue, SS Rathore, P Frame, … - Annals of internal medicine, 2003 - Am Coll Physicians Background: Type 2 diabetes mellitus is associated with a heavy burden of
suffering. Screening for diabetes is controversial. ... Purpose: To examine the
evidence that screening and earlier treatment are effective in reducing ... Cited by 95 - Related articles - BL Direct - All 9 versions
AD Mooradian - Archives of Internal Medicine, 2003 - Am Med Assoc Cardiovascular disease is the most prevalent and detrimental complication of
diabetes mellitus. The incidence of cardiovascular mortality in diabetic
subjects without a clinical history of previous cardiac events is as high ... Cited by 77 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org GL Bakris, E Gaxiola, FH Messerli, G Mancia, … - Hypertension, 2004 - Am Heart Assoc The INternational VErapamil SR-Trandolapril study (INVEST) had 6400 of 22 576
(28.3%) participants with diabetes at entry. The objectives of this prespecified
analysis were to compare antihypertensive treatment strategies in the ... Cited by 73 - Related articles - BL Direct - All 7 versions
- ►annals.org [PDF] AB Rosen, MB Hamel, MC Weinstein, DM … - Annals of Internal Medicine, 2005 - Am Coll Physicians Background: Angiotensin-converting enzyme (ACE) inhibitors slow renal disease
progression and reduce cardiac morbidity and mortality in patients with
diabetes. Patients' out-of-pocket costs pose a barrier to using this ... Cited by 70 - Related articles - BL Direct - All 12 versions
G Mancia - Acta Diabetologica, 2005 - Springer Abstract Diabetes and hypertension frequently coexist, and their combination
provides additive increases in the risk of life-threatening cardiovascular
events. Recent guidelines agree on the need for early, aggressive reduction ... Cited by 62 - Related articles - All 3 versions
BN Mankovsky, D Ziegler - Diabetes/Metabolism Reviews - interscience.wiley.com The article's objective is to review the key advances in the scientific
literature related to the association of stroke with diabetes mellitus and to
summarize the current approaches to stroke prevention in diabetic patients. ... Cited by 50 - Related articles - BL Direct - All 3 versions
MC Blendea, SI McFarlane, ER Isenovic, G … - Current Diabetes Reports, 2003 - Springer Introduction Both type 1 and type 2 diabetes are associated with an increased
risk of cardiovascular disease (CVD) [1–9]. Fur- ther, coronary heart disease
(CHD) mortality is increased threefold in diabetic men [1,2,8] and two- to ... Cited by 46 - Related articles - BL Direct - All 2 versions
A Niklason, T Hedner, L Niskanen, J Lanke - Journal of Hypertension, 2004 - journals.lww.com Objective The Captopril Prevention Project (CAPPP) was designed as a prospective
intervention trial comparing the effect of a treatment based on the
angiotensin-converting enzyme (ACE) inhibitor captopril with that of a ... Cited by 42 - Related articles - BL Direct - All 4 versions
SE Kjeldsen, S Julius - American Heart Journal, 2004 - Elsevier The renin-angiotensin-aldosterone system has a pivotal role in the short- and
long-term regulation of blood pressure through its principal mediator,
angiotensin II. Angiotensin-converting enzyme (ACE) inhibitors and ... Cited by 36 - Related articles - All 13 versions
